Core Laboratories Inc.

CLB

US21867A1051

Business Support Services

Market Closed - Nyse Other stock markets 04:00:02 2024-05-10 pm EDT			5-day change	1st Jan Change
17 ^USD	-0.53%		+6.78%	-3.74%

Apr. 25	Transcript : Core Laboratories Inc., Q1 2024 Earnings Call, Apr 25, 2024
Apr. 24	Earnings Flash (CLB) CORE LABORATORIES Reports Q1 Revenue $129.6M, vs. Street Est of $124.5M	MT

Core Laboratories N.V. Appoints Kwaku Temeng as Supervisory Class Iii Director

May 19, 2021 at 05:30 pm EDT

Core Laboratories N.V. announced that at the AGM held on May 19, 2021, it has approved appointment of Kwaku Temeng as supervisory class III director.

Latest news about Core Laboratories Inc.

Transcript : Core Laboratories Inc., Q1 2024 Earnings Call, Apr 25, 2024	Apr. 25
Earnings Flash (CLB) CORE LABORATORIES Reports Q1 Revenue $129.6M, vs. Street Est of $124.5M	Apr. 24	MT
Earnings Flash (CLB) CORE LABORATORIES Reports Q1 EPS $0.19, vs. Street Est of $0.16	Apr. 24	MT
Core Laboratories Inc. Approves Cash Dividend, Payable on May 28, 2024	Apr. 24	CI
Core Laboratories Inc. Provides Earnings Guidance for the Second Quarter of 2024	Apr. 24	CI
Core Laboratories Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 24	CI
Core Laboratories Inc. Announces Executive Changes	Mar. 25	CI
Transcript : Core Laboratories Inc., Q4 2023 Earnings Call, Feb 01, 2024	Feb. 01
Earnings Flash (CLB) CORE LABORATORIES Posts Q4 Revenue $128.2M, vs. Street Est of $127.6M	Jan. 31	MT
Earnings Flash (CLB) CORE LABORATORIES Posts Q4 EPS $0.19, vs. Street Est of $0.19	Jan. 31	MT
Core Laboratories Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Jan. 31	CI
Core Laboratories Inc. Approves Cash Dividend, Payable on March 4, 2024	Jan. 31	CI
Core Laboratories Inc. Provides Earnings Guidance for the First Quarter of Fiscal Year 2024	Jan. 31	CI
Core Laboratories Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Jan. 31	CI
Stifel Adjusts Price Target on Core Laboratories to $21 From $23, Maintains Hold Rating	Jan. 29	MT
Transcript : Core Laboratories Inc., Q3 2023 Earnings Call, Nov 02, 2023	Nov. 02
Core Laboratories Q3 Adjusted Earnings Rise, Revenue Slips; Issues Q4 Guidance	Nov. 02	MT
Earnings Flash (CLB) CORE LABORATORIES Posts Q3 EPS $0.22, vs. Street Est of $0.22	Nov. 01	MT
Earnings Flash (CLB) CORE LABORATORIES Posts Q3 Revenue $125.3M, vs. Street Est of $130M	Nov. 01	MT
Core Laboratories Inc. Approves Cash Dividend for the Fourth Quarter of 2023, Payable on December 4, 2023	Nov. 01	CI
Core Laboratories Inc. Provides Consolidated Earnings Guidance for the Fourth Quarter of 2023	Nov. 01	CI
Core Laboratories Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 01	CI
Halliburton, Core Laboratories Partner to Provide Digital Rock Simulations	23-10-09	MT
Citigroup Trims Price Target on Core Laboratories to $20 From $21, Maintains Sell Rating	23-09-18	MT
Piper Sandler Adjusts Core Laboratories' Price Target to $21 From $18, Keeps Neutral Rating	23-07-31	MT

Core Laboratories Inc. is a provider of proprietary and patented reservoir description and production enhancement services and products for the oil and gas industry. The Company helps to evaluate and improve reservoir performance and increase oil and gas recovery from new and existing fields. It makes measurements of reservoir rocks, reservoir fluids (crude oil, natural gas and water) and their derived products. In addition, the Company assists clients in evaluating subsurface targets associated with carbon capture and sequestration projects or initiatives. The Company has two segments. Reservoir Description segment provides laboratory-based analytical and field services to characterize the properties of crude oil and crude oil-derived products for the oil and gas industry. In addition, it provides reservoir description capabilities. Production Enhancement segment provides integrated diagnostic services. The Company has approximately 70 offices in more than 50 countries.

Sector

Business Support Services

Calendar

2024-07-23 - Q2 2024 Earnings Release (Projected)

Related indices

Russell 2000

More about the company

Income Statement Evolution

More financial data

Ratings for Core Laboratories Inc.

Trading Rating

Investor Rating

ESG Refinitiv

B+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

17 USD

Average target price

19.33 USD

Spread / Average Target

+13.73%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Testing Laboratories

	1st Jan change	Capi.
CORE LABORATORIES INC.	-3.74%	797M
SGS SA	+13.37%	17.17B
UL SOLUTIONS INC.	0.00%	7.34B
CENTRE TESTING INTERNATIONAL GROUP CO. LTD.	-11.55%	2.91B
CHINA AUTOMOTIVE ENGINEERING RESEARCH INSTITUTE CO., LTD.	-10.79%	2.74B
HEFEI CHIPMORE TECHNOLOGY CO.,LTD.	-29.59%	1.79B
GRG METROLOGY & TEST GROUP CO., LTD.	-0.07%	1.19B
CHINA NATIONAL ELECTRIC APPARATUS RESEARCH INSTITUTE CO., LTD.	-6.77%	1.07B
CHINA TESTING & CERTIFICATION INTERNATIONAL GROUP CO.,LTD.	-10.71%	834M
PONY TESTING CO., LTD.	-13.46%	772M

Testing Laboratories

Core Laboratories Inc.

Equities

CLB

US21867A1051

Business Support Services

Core Laboratories N.V. Appoints Kwaku Temeng as Supervisory Class Iii Director

Latest news about Core Laboratories Inc.

Chart Core Laboratories Inc.

Company Profile

Income Statement Evolution

Ratings for Core Laboratories Inc.

Analysts' Consensus

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Testing Laboratories